Diagnosis of Prostatic Intraepithelial Neoplasia: Prostate Working Group 1 Consensus Report

REFERENCES

• Orteil H. Involutionary changes in prostate and female breast cancer in relation to cancer development. Can Med Assoc J 1926; 16: 237.
   PubMedGoogle Scholar
• Andrews GS. Latent carcinoma of the prostate. J Clin Pathol 1949; 2: 197.
   PubMed Web of Science ®Google Scholar
• Kastendieck H. Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histologi-calstudy of 180 total prostatectomies. Pathol Res Pract 1980; 169: 366–87.
   PubMed Web of Science ®Google Scholar
• McNeal JE. Morphogenesis of prostatic carcinoma. Cancer 1965; 18: 1659�66
   Web of Science ®Google Scholar
• McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986; 17: 64–71.
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987; 59: 788�94.
   Web of Science ®Google Scholar
• Bostwick DG Prostatic intraepithelial neoplasia (PIN) Urology 1989; 34 Suppl 6: 16�22.
   Google Scholar
• Reyes AO, Swanson PE, Carbone JM, et al. Unusual histologic types of high grade prostatic intraepithelial neoplasia. Am J Surg Pathol 1997; 21: 1215�22.
   Web of Science ®Google Scholar
• Berman DM, Yang J, Epstein JI. Foamy gland highgrade prostatic intraepithelial neoplasia. Am J Surg Pathol 2000; 24: 140�4.
   Web of Science ®Google Scholar
• Bostwick DG, Amin MB, Dundore P. et al. Architectural patterns of high grade prostatic intraepithelial neoplasia. Hum Pathol 1993; 24: 298–310.
   Google Scholar
• Qian J, Wollan P, Bostwick DG. The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol 1997; 28: 143�8.
   Google Scholar
• McNeal JE. The significance of duct-acinar dysplasia in prostatic carcinogenesis. Prostate 1988; 13: 91�102.
   Web of Science ®Google Scholar
• da Silva VD, Montironi R, Thompson D, et al. Chromatin texture in high grade prostatic intraepithelial neoplasia and early invasive carcinoma. Anal Quant Cytol Histol 1999; 21: 113�20.
   Google Scholar
• McNeal JE, Villers A, Redwine EA, et al. Microcarci-noma in the prostate: its association with duct-acinar dysplasia. Hum Pathol 1991; 22: 644–52.
   PubMed Web of Science ®Google Scholar
• Boehm N, Sandritter W. DNA in human tumors: a cytophotometric study. Curr Top Pathol 1975; 60: 151�219.
   Google Scholar
• Montironi R, Thompson D, Bartels PH. Premalignant lesions of the prostate. In: Lowe DG, Underwood JCE, eds. Recent advances in histopathology. 1999: l47�72.
   Google Scholar
• McNeal JE, Haillot O, Yemoto C. Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate 1995; 27: 258�68.
   Google Scholar
• Qian J, Jenkins RB, Bostwick DG. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situhybridization. Mod Pathol 1997; 10: 1113�9.
   Google Scholar
• Qian J, Bostwick DG, Takahashi S, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995; 55: 5408�14.
   Web of Science ®Google Scholar
• Epstein JI, Cho KIR, Quinn BD. Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer 1990; 65: 2321�7.
   Google Scholar
• Quinn BD, Cho KR, Epstein JI. Relationship of severe dysplasia to stage B adenocarcinoma of the prostate. Cancer 1990; 65: 2328–37.
   Google Scholar
• Sakr WA, Grignon DJ, Haas GP, et al. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 1996; 30: 138–44.
   PubMed Web of Science ®Google Scholar
• Pacelli A, Bostwick DG. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. Urology 1997; 50: 355–9.
   PubMed Web of Science ®Google Scholar
• Gaudin PB, Sesterhenn IA, Wojno KJ, et al. Incidence and clinical significance of high-grade prostatic intra-epithelial neoplasia in TURP specimens. Urology 1997; 49: 558–63.
   PubMed Web of Science ®Google Scholar
• Harvei S, Skjorten FJ, Robsahm TE, et al. Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway. Br J Cancer 1998; 78: 46–9.
   PubMed Web of Science ®Google Scholar
• Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer 1985; 56: 1566–73.
   Google Scholar
• Montironi R, Mazzucchelli R, Marshall JR, et al. Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents. J Clin Pathol 1999; 52: 793–803.
   PubMed Web of Science ®Google Scholar
• Akakura K, Bruchovsky N, Goldemberg N, et al. Effects of intermittent androgen suppression on androgen-dependent tumors. Cancer 1993; 71: 2782–90.
   PubMed Web of Science ®Google Scholar
• Magi-Galluzzi C, Montironi R, Giannulis I, et al. Prostatic invasive adenocarcinoma. Effect of combina-tion endocrine therapy (LHRH agonist and flutamide) on the expression and location of proliferating cell nuclear antigen (PCNA). Pathol Res Pract 1993; 189: 1154–60.
   Google Scholar
• Montironi R, Diamanti L, Pomante R, et al. Prostatic intraepithelial neoplasia following six-month treatment with a 5-a-reductase inhibitor (finasteride). Anal Quant Cytol Histol 1996; 18: 461–71.
   PubMed Web of Science ®Google Scholar
• Vailancourt L, Tetu B, Fradet Y, et al. Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. Am J Surg Pathol 1996; 20: 86–93.
   PubMed Web of Science ®Google Scholar
• Ferguson J, Zincke H, Ellison E, et al. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology 1994; 44: 91–5.
   PubMed Web of Science ®Google Scholar
• Armas OA, Aprikian AG, Melamed J, et al. Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adeno-carcinoma. Am J Surg Pathol 1994; 18: 979–91.
   PubMed Web of Science ®Google Scholar
• Montironi R, Schulman CC. Pathological changes in prostate lesions after androgen manipulation. J Clin Pathol 1998; 51: 5–12.
   PubMed Web of Science ®Google Scholar
• Cheng L, Cheville JC, Pisansky TM, et al. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol 1999; 23: 803–8.
   PubMed Web of Science ®Google Scholar
• Wheeler TM. Influence of irradiation and androgen ablation on prostatic intraepithelial neoplasia. Eur Urol 1996; 30: 261–4.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Grignon DJ, Humphrey PA, et al. Inter-observer reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995; 19: 873–86.
   PubMed Web of Science ®Google Scholar
• Allam CK, Bostwick DG, Hayes JA, et al. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod Pathol 1996; 9: 742–51.
   PubMed Web of Science ®Google Scholar
• Montironi R, Mazzucchelli R, Bostwick DG, et al. Recent advances in the quantitative morphological evaluation of prostate neoplasia. J Urol Pathol 2000: in press.
   Google Scholar
• Montironi R, Mazzucchelli R, Santinelli A, et al. Case diagnosis as positive identification in prostatic neopla-sia. Anal Quant Cytol Histol 1998; 20: 424–36.
   PubMed Web of Science ®Google Scholar
• Qian J, Bostwick DG. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adeno-matous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. Pathol Res Pract 1995; 191: 860–7.
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Cheng L. Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol 1999; 17: 199–205.
   PubMedGoogle Scholar
• Helpap B, Bonkhoff H, Cockett A, Montironi R, Troncoso P, Waters D, et al. relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN), and prostatic adenocar-cinoma. Pathologica 1997; 89: 288–300.
   PubMedGoogle Scholar
• Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993; 24: 819–32.
   Google Scholar
• Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 1998; 58: 389–91.
   Google Scholar
• Pretlow TG, Nagabhushan M, Pretlow TP. Prostatic intraepithelial neoplasia and other changes during promotion and progression. Path Res Pract 1995; 191: 842–9.
   Google Scholar
• Montironi R, Hamilton PW, Scarpelli M, et al. Subtle morphological and molecular changes in normal-looking epithelium in prostates with prostatic intraepithelial neoplasia or cancer. Eur Urol 1999; 35: 468–73.
   PubMed Web of Science ®Google Scholar
• Montironi R, Galluzzi CM, Diamanti L, Taborro R, Scarpelli M, Pisani E. Prostatic intra-epithelial neo-plasia. Qualitative and quantitative analyses of the blood capillary architecture thin tissue sections. Pathol Res Pract 1993; 189: 542–8.
   Google Scholar
• Kallabury BVS, Brien TP, Lowry CV, et al. Telomerase activity in human benign prostate tissue and prostatic adenocarcinoma. Diagn Mol Pathol 1997; 6: 192–8.
   PubMedGoogle Scholar
• Scates DK, Muir GH, Venitt S, et al. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol 1997; 80: 263–8.
   PubMedGoogle Scholar
• De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999; 155: 1985–92.
   PubMed Web of Science ®Google Scholar